Abstract
A commercially available, direct to consumer, FDA-registered device called the Mira Fertility Tracker (“Mira”), measures quantitative urinary hormone levels via immunofluorescence for ovulation monitoring with a comparable accuracy to clinical immunoanalyzers. While Mira is marketed for use in physiological cycles, the ability to quantify estrone 3-glucuronide (E3G), the urinary metabolite of estradiol (E2), may provide an alternative to serum E2 measurements during IVF.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
